Factors That Are Associated With Parental Acceptance of Human Papillomavirus Vaccines: A Randomized Intervention Study of Written Information About HPV

Dempsey, Amanda F.; Zimet, Gregory D.; Davis, Robert L.; Koutsky, Laura A.

doi:10.1542/peds.2005-1381

Cited by 404 publications

(410 citation statements)

References 24 publications

Supporting

Mentioning

357

Contrasting

Unclassified

Order By: Relevance

“…Furthermore, although parents of unvaccinated boys reported similar or greater agreement than parents of unvaccinated girls with statements about HPV vaccine safety and efficacy, they were also more likely to agree it is more important for girls to get HPV vaccine. Some prior research suggests parental knowledge about HPV and HPV vaccination is generally not associated with vaccine acceptability or vaccination initiation; 25,37 however, parental attitudes and beliefs related to HPV disease and vaccination are associated with acceptability and initiation. 18,25,26 Dorell et al found concerns about HPV vaccine safety and effectiveness were reported more often by parents who refused HPV vaccination for their adolescents than parents who delayed but did not refuse vaccination.…”

Section: ããmentioning

confidence: 98%

“…9,12,[21][22][23][24] Similarly, parents report -and clinicians perceive -greater parental acceptability of HPV vaccine for older teens. 9,12,21,[25][26][27] Vaccination coverage estimates for 1 and 3 doses of HPV vaccine are notably lower among boys than girls; 7 this is partially attributable to the fact that the routine recommendation for HPV vaccination of adolescent boys is comparatively recent. One previous study suggested differences between male and female adolescents in correlates of vaccine receipt and reasons for nonvaccination; 28 few studies have compared the sexes.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Comparing human papillomavirus vaccine knowledge and intentions among parents of boys and girls

Lindley

Jeyarajah

Yankey

et al. 2016

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

Background/Objective: Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States. Previous research suggests some differences between male and female adolescents in correlates of vaccine receipt and reasons for non-vaccination; few studies examine both sexes together. This analysis assessed knowledge and attitudes related to HPV disease and vaccination, intention to vaccinate, and reasons for delayed vaccination or non-vaccination among parents of boys and girls 13-17 y old in 50 states, the District of Columbia, and selected local areas. Methods: National Immunization Survey-Teen 2013 data were analyzed and gender differences examined. Results: In this sample, adolescent boys were more likely than girls to be unvaccinated and less likely to have completed the HPV vaccination series (p < 0.005 for both). Parents of girls were more likely than parents of boys to report a provider recommendation for HPV vaccination (65.0% vs. 42.1%). Only 29% of girls' parents reported a provider recommendation to begin vaccination by 11-12 y old. Among unvaccinated teens, parental intention to vaccinate in the next 12 months did not differ by sex, but reasons for vaccination or nonvaccination did. Many parents do not know the recommended number of HPV doses. Conclusions: Gender differences in provider vaccination recommendations and reasons for vaccination might partially explain differential HPV uptake by male and female adolescents. Clinicians should offer strong recommendations for HPV vaccination at 11-12 y old for both girls and boys. To reduce missed opportunities, HPV vaccination should be presented in the context of, and given concurrently with, other routinely administered vaccines.

show abstract

Section: ããmentioning

confidence: 98%

Section: Introductionmentioning

confidence: 99%

Comparing human papillomavirus vaccine knowledge and intentions among parents of boys and girls

Lindley

Jeyarajah

Yankey

et al. 2016

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

show abstract

“…Numerous studies have demonstrated that public awareness of HPV, perceived risks of HPV infection, and knowledge of potential health consequences of HPV infection are low [8][9][10]. Factors associated with the acceptability of the HPV vaccine are knowledge about the disease, beliefs about vaccines, physician recommendation, previous experience with HPV infections, perceived risk for HPV infection, perceived vaccine safety and efficacy, and perceived vaccination would promote adolescent sexual behavior [11][12][13].…”

Section: Introductionmentioning

confidence: 99%

Knowledge and Attitudes About HPV Infection, HPV Vaccination, and Cervical Cancer Among Rural Southeast Asian Women

Wong

2010

Int.J. Behav. Med.

View full text Add to dashboard Cite

Background The incidence of cervical cancer in developing countries is high and even higher among women in rural areas in these countries. Purpose The purpose of this study is to assess the knowledge and attitudes towards human papillomavirus (HPV), HPV vaccination, and cervical cancer among young women in rural settings in a Southeast Asia country. Methods A convenience sample of ethnically diverse young rural women in Malaysia was surveyed. Participants were interviewed using a standard questionnaire. Results Among the participants (N=449), knowledge of HPV, HPV vaccination, cervical screening, and cervical cancer risk factors was extremely poor. The mean total knowledge score (14 items) was 2.37 (SD±1.97). Although many had never heard of the newly released HPV vaccine, two-thirds professed an intention to receive the HPV vaccine. Intention to receive the vaccine was significantly associated with knowledge of cervical screening and cervical cancer risk factors (OR 1.17; 95% CI 1.03-1.33; P=0.013). Reasons for vaccine refusal were doubts about safety and efficacy of the new vaccine (27.4%), perceived embarrassment at receiving an STI vaccine (20.7%), and perception of not being at risk of HPV infection (20.0%). Conclusions Providing HPV education to the rural residents is a high priority.

show abstract

“…Une enquête réalisée en Californie (États-Unis) auprès de mères de filles âgées de moins de 18 ans révèle que 75 % d'entre elles estiment que l'âge idéal de la vaccination se situe avant 13 ans [10]. À l'inverse, dans une autre étude américaine, l'acceptabilité est jugée meilleure à l'adolescence qu'avant [11]. Dans d'autres enquêtes réalisées en Suède, Belgique et Nouvelle-Zélande, l'âge optimal varie également entre 12 et 17 ans [4].…”

Section: Acceptabilité De La Vaccinationunclassified

Vaccins contre les papillomavirus humains (HPV)

Heard

Floret

2013

Med Sci (Paris)

View full text Add to dashboard Cite

Entre 2005 et 2011, le Comité technique des vaccinations et le Conseil supérieur d'hygiène publique deFrance, puis le Haut conseil de la santé publique (HCSP) qui lui a succédé, ont émis 11 avis relatifs à la vaccination contre le papillomavirus (voir Encadré). L'avis princeps [1], en date du 9 mars 2007, recommandait la vaccination par le vaccin quadrivalent (alors seul disponible) (voir Encadré) des jeunes filles de 14 ans, ainsi que le rattrapage chez les jeunes filles et les jeunes femmes jusqu'à l'âge de 23 ans révolus qui n'auraient pas eu de rapports sexuels, ou au plus tard dans l'année suivant le début de leur activité sexuelle. > L'âge de la vaccination contre le papillomavirus a été récemment modifié par le Haut conseil de la santé publique (HCSP). Les éléments qui ont contribué à l'élaboration de ce nouvel avis sont détaillés dans cet article, en particulier les résultats des études qui ont décrit les facteurs d'acceptabilité des vaccins par les familles et par les praticiens. L'hypothèse d'une vaccination avec seulement deux doses est posée à partir des résultats d'études concluant à l'efficacité d'un schéma simplifié. Enfin, les premiers résultats d'efficacité clinique du vaccin quadrivalent, tant sur les condylomes que sur les lésions précancé-reuses du col de l'utérus, sont présentés. Au plan virologique, une diminution de la prévalence de l'infection par les virus dont les génotypes sont compris dans les vaccins a été rapportée dans plusieurs études. Cette diminution, importante et précoce après la mise en place des vaccins, semble en partie liée à l'existence d'une immunité de groupe. <

show abstract

Factors That Are Associated With Parental Acceptance of Human Papillomavirus Vaccines: A Randomized Intervention Study of Written Information About HPV

Cited by 404 publications

References 24 publications

Comparing human papillomavirus vaccine knowledge and intentions among parents of boys and girls

Comparing human papillomavirus vaccine knowledge and intentions among parents of boys and girls

Knowledge and Attitudes About HPV Infection, HPV Vaccination, and Cervical Cancer Among Rural Southeast Asian Women

Vaccins contre les papillomavirus humains (HPV)

Contact Info

Product

Resources

About